
news
By Sai Krishna
SHANGHAI , Oct. 13, 2026 /PRNewswire/ -- Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio") today announced that the U.S. Food and Drug Administration (FDA) has granted its investigational new drug (IND) application for AK0406, a long-acting antiviral drug-Fc conjugate (AFC), enabling the company to initiate a phase II clinical trial for influenza prevention in general population in the United States. Addressing...

news
news

news
Cell Impact announces acceleration of previously communicated order from US customer...
12 Oct 2026, 05:30 pm

news
Malou Oheix from France Wins First Place in 2026 Herbie Hancock Institute International Jazz Vocals Competition at Fondation Louis Vuitton...
12 Oct 2026, 04:31 pm

news
Geely Auto Group Makes Its Paris Motor Show Debut with Geely Auto, Lynk & Co and Zeekr...
12 Oct 2026, 04:30 pm

news
AION UT Cross Makes Global Debut as GAC Showcases All-Star Lineup at 2026 Paris Motor Show...
12 Oct 2026, 03:33 pm

news
GAC Unveils New Brand, Services and Products at 2026 Paris Motor Show, Marking a New Chapter in Full-Chain Localization in Europe...
12 Oct 2026, 03:32 pm

news

news

news

news
Mon Oct 12 2026

Mon Oct 12 2026
Mon Oct 12 2026

Mon Oct 12 2026
Mon Oct 12 2026
Mon Oct 12 2026
Mon Oct 12 2026

Mon Oct 12 2026